Quick Answer
Catheter Precision, Inc. reported Diluted EPS of $25.98 per share (loss) for fiscal year 2022.
Catheter Precision, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2022 | -$25.98 | +89.5% |
| 2021 | -$248.22 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | -$4.36 | +87.0% | -1576.9% |
| June 30, 2022 | -$0.26 | +79.7% | +99.2% |
| September 30, 2021 | -$33.58 | — | -2523.4% |
| June 30, 2021 | -$1.28 | — | — |
- Catheter Precision, Inc. showed an increase of +89.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2022 period, Catheter Precision, Inc.’s diluted eps has grown by 89.5% (from $248.22 per share (loss) to $25.98 per share (loss)).
- The most recent figure is from Catheter Precision, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 28, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: